Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Soligenix Inc (OTCBB - OTCQB:SNGX)

0.8997
Delayed Data
As of Feb 05
 -0.0003 / -0.03%
Today’s Change
0.44
Today|||52-Week Range
2.95
-20.38%
Year-to-Date
No recent news for Soligenix Inc.

Today’s Trading

Previous close0.90
Today’s open0.90
Day’s range0.85 - 0.92
Volume39,614
Average volume (3 months)215,455
Market cap$24.5M
Dividend yield--
Data as of 3:56pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+33.85%
Earnings growth (this year)+32.56%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+118.45%
P/E ratioNM
Price/Sales3.28
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GENEGenetic Technologies...-0.08-3.65%
--Cell Source Inc0.000.00%
ICCCImmuCell Corp-0.03-0.48%
BNTCBenitec Biopharma Lt...0.000.00%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 23, 2016
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$7.0M
Annual profit (last year)-$6.7M
Net profit margin-95.23%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Christopher J. Schaber
Chief Financial Officer, Secretary &
VP
Joseph Michael Warusz
Corporate headquarters
Princeton, New Jersey

Forecasts

Partner Offers